Applied DNA Signs Memorandum of Understanding with Process Chemicals Leader Stahl to Bring CertainT® Platform to Manufacturi...
April 12 2019 - 3:00AM
Business Wire
Partnership to Accelerate Product Development
and Path to Market Within Manufacturing Supply Chains Including
Leather
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”,
the “Company”), a leader in PCR-based DNA manufacturing for product
authenticity and traceability solutions, announced today the
signing of a non-binding Memorandum of Understanding (“MOU”) with
Netherlands-based Stahl, the world leader in process chemicals for
leather products, performance coatings and other substrates. The
MOU is expected to be followed by a definitive agreement.
Under the terms of the MOU, the parties will continue the
evaluation of molecular tagging of process chemicals and coatings
utilizing Stahl’s product offerings as a point of entry into supply
chains for the Company’s molecular tags. Stahl will provide
technical expertise to the company relating to the process
chemicals used in leather manufacturing.
Dr. James Hayward, President and CEO of Applied DNA, said,
“Stahl’s global sales and support footprint, coupled with broad
access to its customer base that spans global brands and their
supply chains, makes it an ideal partner through which to expand,
implement and support our CertainT® authentication and traceability
platform. We believe this partnership should accelerate our entry
into the leather market. We look forward to a long and productive
relationship with Stahl.”
Mike Costello, Director of Sustainability at Stahl, said “We see
a bright future for molecular tagging. Leather is just one of many
industries which could benefit by having the capability to improve
traceability. As a process chemical manufacturer, we are a logical
point of entry into a whole range of supply chains for Applied
DNA’s molecular tags.”
About Stahl
Stahl is the world leader in leather chemicals and
high-performance coatings. Our products provide functionality,
durability and comfort to many different materials used in everyday
life. Through our continuous focus on innovation and improving the
environmental footprint, Stahl adds value to differentiated
high-end industries with a unique service model for premium
solutions. As part of its corporate responsibility, Stahl is
actively driving change in the industry by initiating activities
that promote transparency and to provide environmental solutions
for the supply chain, involving close collaboration with its
partners.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance and various other factors
detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
18, 2018 and our subsequent quarterly report on Form 10-Q filed on
February 7, 2019, and other reports we file with the SEC, which are
available at www.sec.gov. Applied DNA undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190412005058/en/
investor:Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.comMedia:Meryl Rader,
781-639-4924, meryl@cgprpublicrelations.comProgram:Tony
Benson, 44 (0) 7552 429341, tony.benson@adnas.comWeb:www.adnas.comTwitter:@apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024